Simulating Surgery
Vascular surgeons plan most arterial bypass grafts on the basis of experience and intuition: only after surgery is there a way to tell whether an artery has been grafted to the place best suited to restore blood flow with minimal complications. But a group led by Charles Taylor, a Stanford University mechanical engineer who studies the human vascular system, is proving the power of an experimental software system that lets surgeons “sketch” several possibilities and preview the likely results before making a single incision.
The process starts with the collection of three-dimensional nuclear magnetic resonance data that describe the patient’s anatomy-the exact shape of the coronary or carotid arteries, for instance-along with snapshots of blood flow at various points. Taylor’s software converts the anatomical data into a numerical “mesh” that represents the vessels, and surgeons use computer-aided design to add hypothetical bypass grafts to the mesh. Next, a supercomputer applies fluid dynamics equations to the original flow data, producing a color-coded simulation of blood coursing through the newly configured mesh. By using the simulations to test a variety of graft placements, surgeons can plan operations that don’t inadvertently create areas of low blood flow, a cause of clotting that can lead to heart attacks and strokes.
In retrospective comparisons of data from two human patients who received bypasses in their lower extremities, the system’s suggested predictions “probably would have changed how the procedures were performed,” says Taylor, who hopes that within five years he’ll have made the simulations fast and reliable enough for regular use in surgical planning. He says that “10 or 20 years from now every single [cardiovascular] patient is going to be treated this way.”
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.